Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
about
A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cellsThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells.Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsA FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mappingDifferential activation of innate immune responses by adenovirus and adeno-associated virus vectorsAdeno-associated Virus as a Mammalian DNA VectorAdeno-associated virus for cystic fibrosis gene therapyParvovirus glycan interactionsAdeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveParvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosisPolymers for improving the in vivo transduction efficiency of AAV2 vectorsAdeno-associated virus: from defective virus to effective vectorStructural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal TraffickingElectron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virusParticle tracking in drug and gene delivery research: State-of-the-art applications and methodsRecombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microgliaApplying gene silencing technology to contraceptionA common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes.Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening.Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.Efficient active transport of gene nanocarriers to the cell nucleus.Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues.Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network.Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment.Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsMonoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infectionDesigner gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferPrevention of chemotherapy-related toxic side effects by infection with adeno-associated virus type 2.Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cellsEndocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.AAV's anatomy: roadmap for optimizing vectors for translational successGene and cell-mediated therapies for muscular dystrophy.Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblastsRecombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.
P2860
Q21142728-AA57572A-C4A6-42B0-9F09-18166D03DFC6Q24533492-75D327AE-88E3-499A-B4A8-E4AEFE139289Q24538924-AFE6E5FF-EAD1-4D2E-B6EC-FC269470464EQ24623923-1ADCA194-35B1-43E8-AD33-AA1E6BA25014Q24651191-093C4EC0-FACD-42FA-A6DB-E490A2BD01FDQ24673796-0F838E3D-4AD1-4A69-84AD-D8F0BE6526D4Q26782605-7EEEB5B8-5992-4BD9-B8A3-8C63BCA78AD5Q26823156-25A7A0FE-1001-4C9D-AD8D-244074B546FBQ26858992-D4C6FAF9-E0D1-418B-A777-C98D99C94224Q27012320-0B1D153A-0802-4409-A98D-642D4339BE1BQ27332338-C88BF5BF-1B2A-4A24-A400-5617FA7BD6FDQ27438107-C54CDD70-0B03-4CE4-BFEF-79589CBFB42FQ27498163-A9DD0FD2-ECE0-412F-9B7C-31F258A88E5FQ27673394-07A6E7C8-C42C-4570-B47F-7145F7548814Q27679952-C1064FB8-1E8E-4F9D-9266-80864647C1B3Q28087396-2CBCA9CC-EA7A-445E-8554-DE1F694D36D9Q28386583-CE7525B0-7373-441C-B3D0-16B6F58BD79CQ28703567-B637C1D4-0448-41F5-83F7-29780569BD18Q30445618-FB74ED50-301C-49F4-B24C-8E270DAB88A3Q30457601-AEF44394-CBAC-44CA-A232-442767D7E4CEQ30476153-62AFBFAF-457D-4D48-92E5-45091C1BF67DQ30477726-E749F13F-99BB-42FF-84D0-BB7393A0760AQ30495947-5739D2FE-5C18-482C-9433-639BAE894F1DQ30505116-FCDA41AF-254E-4FD1-BF2B-C1840F22D414Q30525258-3BA09815-5BCF-41E3-AC7E-5BDB296F3B7BQ30573520-859E56F7-295F-426D-9C69-8890FFE4EE2FQ30650955-B474FD75-6EF0-45A9-8839-1094A532627CQ30923081-8284411C-CC5C-466D-8C6B-7C14FD6BA869Q33296224-FF774E42-5688-45A8-8687-10AC7FE114E5Q33343268-71DA0FF6-2939-41F1-9CD6-E5231E4C4F5EQ33558658-AF519926-52C6-4C27-80A7-942B5289FA4BQ33604753-FCBE9574-AC50-4A4F-916A-DB359ECA2926Q33622746-BF178367-504C-41C5-A35A-AE8C474A1F68Q33659389-C404491C-F1A9-4A9D-9FBA-AEF212B45A75Q33831193-83F3994F-EF6E-4298-AD91-56413385D057Q33832799-B8F810D0-7DE5-4316-BEA5-86972A11D284Q33839187-FA498522-8E8F-40CE-9CB5-E43E89E01265Q33839247-DDFE5FE3-ECBC-414D-98B8-8E3F544313F5Q33870310-2468DFC3-DC80-4928-A972-7E75E3B73283Q33908400-924F2DB4-F34E-42EE-B7D6-668F26D1CF8D
P2860
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@en
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@nl
type
label
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@en
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@nl
prefLabel
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@en
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@nl
P2093
P2860
P1433
P1476
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
@en
P2093
J S Bartlett
R J Samulski
P2860
P304
P356
10.1128/JVI.74.6.2777-2785.2000
P407
P577
2000-03-01T00:00:00Z